top of page

Our Services

We offer customizable solutions for academic teams and SMEs through an integrated vaccine development platform. Our end-to-end approach spans AI-driven rational design, biomanufacturing, and preclinical proof of concept, providing flexible access to specialized expertise, infrastructure, and advanced models.

1 

AI-Driven Design & Structural Modeling

  • AI-based protein and complex structure prediction

  • Structural modeling and epitope selection

  • Rational design of proteins, peptides, and biomolecular complexes

  • Functional optimization, oligomerization, and structure-guided engineering

2

Protein Engineering & Expression Systems

Tailored expression strategies to ensure efficient and scalable recombinant protein production.

  • Microbial and mammalian expression system development

  • Recombinant protein engineering and optimization

  • Construct design for yield, stability, and functionality

3

Biomanufacturing & Process Development

End-to-end bioprocess optimization under GLP-like quality standards.

  • Bioprocess development, optimization, and scale-up in bioreactors

  • Process robustness and performance optimization

  • Industrial process validation and risk assessment

4

Peptide & Protein Chemistry, Purification and Biophysical Characterization

Integrated production, purification, formulation, and characterization of proteins, peptides, and biomolecular complexes.

  • Protein, peptide, and small-molecule purification

  • Solid-phase peptide synthesis, purification, and optimization

  • Formulation development and stability profiling

  • Biophysical and biomolecular interaction analysis

  • Screening and lead peptide optimization

  • Characterization of complexes and particulate systems

5

Immunological Evaluation & Immune Profiling

Comprehensive in vitro and in vivo immunology to support candidate selection.

  • Assessment of vaccine- and immunomodulator-induced immune responses

  • Immune profiling to guide optimization and decision-making

  • Mechanistic evaluation of immunogenicity and efficacy

6

Preclinical Proof of Concept

Efficacy validation in relevant animal models through an established collaborator network.

  • In vivo proof-of-concept studies

  • Preclinical efficacy and safety assessment

  • Project-specific quality control and documentation practices

  • Risk evaluation and translational readiness 

bottom of page